Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Sinem Burcu KOCAER"'
Autor:
Sadettin Uslu, Semih Gulle, Gercek Sen, Ayse Cefle, Sema Yilmaz, Sinem Burcu Kocaer, Tuba Yuce Inel, Suleyman Serdar Koca, Servet Yolbas, Mehmet Akif Ozturk, Soner Senel, Nevsun Inanc, Huseyin Ediz Dalkilic, Ozgul Soysal Gunduz, Abdurrahman Tufan, Servet Akar, Ahmet Merih Birlik, Ismail Sari, Nurullah Akkoc, Fatos Onen
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-9 (2024)
Abstract Clinical data on the use of tumour necrosis factor inhibitors (TNFi) in late-onset ankylosing spondylitis (LoAS) are limited. The present study aimed to evaluate efficacy, safety, and treatment adherence associated with the initial use of TN
Externí odkaz:
https://doaj.org/article/07ea3304416b46ad8c900013a1ca1f33
Publikováno v:
European Journal of Rheumatology, Vol 10, Iss 3, Pp 101-106 (2023)
Externí odkaz:
https://doaj.org/article/e3215079dd6f4fd7864bf43d4f35fdad
Autor:
Gerçek CAN, Aydan KÖKEN AVŞAR, Sinem Burcu KOCAER, Gökçe KENAR, Dilek SOLMAZ, Fatoş ÖNEN, Süleyman Serdar KOCA, Ali AKDOĞAN, Merih BİRLİK
Publikováno v:
Namık Kemal Tıp Dergisi, Vol 10, Iss 1, Pp 43-47 (2022)
Aim:Modified Rodnan Skin Score (mRSS) is generally used to assess skin involvement in patients with scleroderma. There are conflicting data on the effectiveness of mRSS training courses in previous studies. The aim of this study to evaluate the effec
Externí odkaz:
https://doaj.org/article/bad96b11d1af490d8e6eac7c942362bb
Autor:
Fatos Onen, Ali Osman Saatci, Ismail Sari, Suzan Guven Yilmaz, Ziya Ayhan, Sinem Burcu Kocaer, Mahmut Kaya
Publikováno v:
Modern Rheumatology. 32:994-998
Objectives Vogt–Koyanagi–Harada Disease (VKHD) is a systemic autoimmune disorder characterized by granulomatous panuveitis. Inflammatory rheumatic diseases (IRDs) are among the differential diagnosis of VKHD. However, current knowledge on the rhe
Autor:
Fatma Alibaz-Oner, Gökhan Keser, Kenan Aksu, Nilufer Alpay-Kanitez, Sema Kaymaz Tahra, Duygu Ersözlü, Ayten Yazici, Osman Faruk Bayramlar, Abdulsamet Erden, Sinem Burcu Kocaer, Onay Gercik, Mete Kara, Gökçe Kenar, Haner Direskeneli, Fatos Onen, Servet Akar, Ahmet Omma, Mehmet Gokhan Gonenli
Background This study aimed to examine fetomaternal outcomes in pregnant women in a large Turkish Takayasu arteritis (TAK) cohort and to evaluate the effects of pregnancy on the disease in those patients. Methods This is a cohort study involving 296
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::480ad1fde367e8ea62d4a7b346925f8c
https://hdl.handle.net/11454/77497
https://hdl.handle.net/11454/77497
Autor:
Ayse Cefle, Mete Kara, Gökhan Keser, Sinem Burcu Kocaer, Kenan Aksu, Fatos Onen, Hakan Emmungil, Haner Direskeneli, O Gerçik, Ö. Özdemir Işik, A Omma, Fatma Alibaz-Oner, Kübra Erol Kalkan, N S Yasar Bilgin, Sema Kaymaz-Tahra, Nilufer Alpay-Kanitez, Ayten Yazici, Timuçin Kaşifoğlu, Servet Akar
Publikováno v:
Scandinavian journal of rheumatology. 51(4)
Objectives Takayasu's arteritis (TAK) is a rare vasculitis characterized by inflammation of intermediate- to large-size arteries. Although pulmonary artery involvement (PAI) is an expected finding in some TAK patients, data on non-vascular pulmonary
Autor:
Gökhan Keser, Kenan Aksu, Hakan Emmungil, B. Ince, Murat Inanc, Sema Kaymaz-Tahra, Ozun Bayindir, Haner Direskeneli, Fatma Alibaz-Oner, Can Ilgin, Ayse Cefle, Fatos Onen, Sinem Burcu Kocaer, Nilüfer Alpay Kanıtez, Timuçin Kaşifoğlu, Servet Akar, Nazife Sule Yasar Bilge, Kübra Erol Kalkan, Ahmet Omma, Ayten Yazici, Elif Durak
Objective: To compare the treatment outcomes of TNF inhibitors and tocilizumab (TCZ) in patients with Takayasu arteritis. Methods: Takayasu arteritis patients who were refractory to conventional immunosuppressive (IS) drugs and received biologic trea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32583f4cd1f1c4fd273191ac49d7c4c4
https://hdl.handle.net/11454/76862
https://hdl.handle.net/11454/76862
Publikováno v:
Rheumatology (Oxford, England). 60(9)
Amac: D vitamini eksikligi lipid metabolizmasi uzerine olumsuz etki olusturmakta ve kardiyovaskuler riski artirmaktadir. Paraoksonaz-1 (PON1) enzim aktivitesi, yuksek dansiteli lipoprotein (HDL) aktivitesini belirleyen faktorlerden birisidir. Bu aras
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::622eb4003e3683c112e40f4cac10ad61
https://avesis.deu.edu.tr/publication/details/c0066661-93cb-4ca1-89eb-8f47a257e452/oai
https://avesis.deu.edu.tr/publication/details/c0066661-93cb-4ca1-89eb-8f47a257e452/oai